Abstract:Background: The majority of HBeAg-positive mothers with chronic hepatitis B have high levels of viremia and inactive disease with normal alanine aminotransferase (ALT) during pregnancy. In addition, postpartum disease activation and ALT flare have been reported in the range of 15 - 35%. However, the current International Association Guidelines have not provided clear recommendations and a risk-stratified monitoring schedule. Furthermore, data are lacking on the definition of normal ALT in the postpartum period in mothers with chronic hepatitis B. The clinical features and ALT flare patterns in HBeAg-positive mothers versus HBeAg-negative mothers are not fully explored. Thus, we design a cohort study to investigate the aforementioned area and generate data to assist healthcare providers in better managing mothers with hepatitis B. We aim to assess the frequency of postpartum ALT flares and predictors for such events. Method: This study is a single-center and prospective cohort study (n = 360) that consists of two groups of patients including HBsAg-positive mothers (n = 120) and healthy mothers without HBV infection (n = 240). In HBeAg-positive mothers, antiviral therapy during late pregnancy is permitted to prevent Mother-to-child transmission (MTCT) but discontinued at delivery if there is no further indication for the treatment. Mothers are enrolled at the gestational weeks of 12-24. After delivery, both mothers and their infants will be followed up until postpartum week 24. Clinical and laboratory data are collected every 4 weeks during the study except there are no follow-up visits at the postpartum weeks 16 and 20. The primary objective is the proportion of patients with postpartum ALT flares. The secondary objectives are independent risk factors during pregnancy for predicting postpartum ALT flares and the normal range of postpartum ALT levels in healthy mothers. Discussion: The current study focuses on the incidence of postpartum ALT flares in mothers with chronic hepatitis B including subgroup analysis based on HBeAg status. The data will have several clinical implications, such as providing evidence for an appropriate monitoring schedule in CHB mothers after delivery. Further analyses on predictors of such events may assist clinicians in identifying mothers who might develop severe postpartum ALT flares. The data generated from healthy mothers have the potential to identify the patterns of ALT changes during pregnancy and postpartum, so we can gain a better understanding of the normal range of ALT in this subpopulation. Trial registration number at the chinese clinical trial registry: ChiCTR2200061130.

Multivariate analysis of prognostic factors for fulminant hepatitis in pregnancy

Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure

Effect of Prophylactic Antiviral Intervention on T Cell Immunity in Hepatitis B Virus-Infected Pregnant Women

Impaired CD8+ T Cells in Term Pregnancy Decidua with Chronic Hepatitis B Virus Infection

Analysis of clinical characteristics and genetic testing in patients with acute fatty liver of pregnancy: a retrospective study

[A real-world study on the features of postpartum hepatitis flares in pregnant women with chronic HBV infection]

Deregulation of immune response contributing to fulminant hepatitis in HEV infected pregnant women

Related Factors of Prognosis for Acute Liver Failure in Critically Ill Children

Maternal HBsAg carriers and adverse pregnancy outcomes: a hospital-based prospective cohort analysis.

Establishing a Metabolomic Model for the Prognosis of Hepatitis B Virus-Induced Acute-on-chronic Liver Failure Treated with Different Liver Support Systems

Liver failure in pregnancy: a review of 25 cases

Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study

Factors and a model to predict three-month mortality in patients with acute fatty liver of pregnancy from two medical centers

Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study

Maternal chronic hepatitis B virus infection and the risk of preterm birth: A retrospective cohort analysis in Chinese women

Menace of hepatitis E in pregnancy: unleashing the threat of fulminant liver failure

Incidence and predictors of elevated postpartum alanine aminotransferase in chronic hepatitis B mothers: a prospective study protocol

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection

Twin pregnancy outcomes of maternal hepatitis B virus carrier state

Postpartum hepatitis flares in mothers with chronic hepatitis B infection

Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China